This information was received as a part of an extensive mesh litigation submission to medtronic.
the fda was notified of this large complaint receipt.
due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of parastomal and ventral hernias.
It was reported that after implant, the patient experienced recurrence, unhealed abdominal wound with infection, adhesions, small bowel obstruction, swelling, erythema, and abscess.
Post-operative patient treatment included removal surgery, ventral hernia repaired with new mesh, multilayer closure with tissue rearrangement, incision and drainage of abdominal wall wound collection, incision and drainage of abscess, and small bowel resection.
|